In the search for greater efficiencies, companies are looking to outsource a wide range of activities. In Drug Discovery this includes everything from a specific function such as compound library synthesis to the establishment of completely virtual companies.
This meeting will look at a variety of outsourcing options both from the payers' and the CRO's perspective with an emphasis on experience of "Best Practice”. Strategies employed to date will be complemented with analyses of their effectiveness and likely future directions.
It is targeted at all those involved in Drug Discovery Outsourcing, whether designing chemistry or screening plans, coordinating ongoing projects, planning strategic collaborations, or just considering this approach as an option.
It will combine a discussion of day to day practicalities and key strategic insights. There is much potential interest for service providers, both scientists working at the bench and those managing services, through a sharing of experience and processes.
This meeting will look at a variety of outsourcing options both from the payers' and the CRO's perspective with an emphasis on experience of "Best Practice”. Strategies employed to date will be complemented with analyses of their effectiveness and likely future directions.
It is targeted at all those involved in Drug Discovery Outsourcing, whether designing chemistry or screening plans, coordinating ongoing projects, planning strategic collaborations, or just considering this approach as an option.
It will combine a discussion of day to day practicalities and key strategic insights. There is much potential interest for service providers, both scientists working at the bench and those managing services, through a sharing of experience and processes.
